COPD - Free CE Continuing Education online pharmacy, pharmacists

More documents

Recommendations

Info

Bronchodilators: SummaryCharacteristicsAgentUseMechanism ofActionAdverse DrugReactionsDosingAnticholinergic+ short-actingβ 2 -agonist 1(combinationipratropiumbromide +albuterol sulfate)MaintenanceReducesbronchospasmthrough 2 pathways:– Anticholinergicpathway– SympathomimeticpathwaySame as individualcomponents; noincrease in risk withcombination therapy4x/dayTheophylline 2 Maintenance Smooth musclerelaxation andsuppression ofbronchospasticresponse to stimuliNausea, vomiting,diarrhea, headache,insomnia,restlessness, cardiacarrhythmias,intractable seizuresDose and frequencyof administrationdepend onformulation.titrate dose to serumconcentration 5-14μg/mL
Therapy Compliance• Lack of patient adherence becomes more significant when:– Daily therapy is required– Multiple products are required• Evidence indicates higher compliance with a less frequentdosing regimen 1-3
Page 4: Overview• Definition of COPD• R
Page 9 and 10: Risk Factors• Primary: cigarette
Page 11 and 12: Pathophysiology of COPDAirflow obst
Page 13 and 14: Spirometry• Lung function reporte
Page 15 and 16: Management Objectives• Prevent di
Page 17 and 18: Step therapy for patients with COPD
Page 19 and 20: Smoking Cessation• Single most ef
Page 21 and 22: Pharmacologic Therapy• Rescue the
Page 23 and 24: Management of Acute Exacerbations
Page 25: Bronchodilators: SummaryCharacteris
Page 29 and 30: Improving care of patients with COP
Page 31 and 32: Improving care of patients with COP
Page 33: Summary• Focus on interventions k

COPD - Free CE Continuing Education online pharmacy, pharmacists

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?